The 93 patients with ESCC were divided into the high (expression > median value, n = 46) and low expression (expression ≤ median value, n = 47) groups according to the median value of the CCAT2 expression (Supplementary Figure 1A). This evidence concerns the gene CCAT2 and esophageal squamous cell carcinoma.